Senate Bill S2722

2017-2018 Legislative Session

Provides that a controlled substance analogue shall be deemed to be the controlled substance to which it is substantially similar or mimics

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Senate Committee Rules Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions
Votes

co-Sponsors

2017-S2722 (ACTIVE) - Details

See Assembly Version of this Bill:
A2970
Current Committee:
Senate Rules
Law Section:
Public Health Law
Laws Affected:
Amd §3302, add §3306-a, Pub Health L; amd §220.00, Pen L
Versions Introduced in Other Legislative Sessions:
2019-2020: S1652, A6757
2021-2022: S1824, A6629
2023-2024: S2855, A4582

2017-S2722 (ACTIVE) - Summary

Provides that a controlled substance analogue shall be deemed to be the controlled substance to which it is substantially similar or mimics.

2017-S2722 (ACTIVE) - Sponsor Memo

2017-S2722 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   2722
 
                        2017-2018 Regular Sessions
 
                             I N  S E N A T E
 
                             January 17, 2017
                                ___________
 
 Introduced  by  Sens. KLEIN, AMEDORE, GALLIVAN, KENNEDY, MURPHY, O'MARA,
   ORTT, SERINO, VALESKY -- read twice  and  ordered  printed,  and  when
   printed to be committed to the Committee on Health
 
 AN  ACT to amend the public health law and the penal law, in relation to
   controlled substance analogues

   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1.  Section 3302 of the public health law is amended by adding
 a new subdivision 44 to read as follows:
   44.  "CONTROLLED SUBSTANCE ANALOGUE" (A) MEANS A SUBSTANCE, THE CHEMI-
 CAL STRUCTURE OF WHICH IS SUBSTANTIALLY SIMILAR TO THE  CHEMICAL  STRUC-
 TURE  OF  A  CONTROLLED  SUBSTANCE LISTED IN SCHEDULE I OR II OF SECTION
 THIRTY-THREE HUNDRED SIX OF THIS TITLE, AND WHICH EITHER:
   (I) HAS A  STIMULANT,  DEPRESSANT  OR  HALLUCINOGENIC  EFFECT  ON  THE
 CENTRAL  NERVOUS SYSTEM THAT MIMICS OR IS SIMILAR TO OR GREATER THAN THE
 STIMULANT, DEPRESSANT OR HALLUCINOGENIC EFFECT ON  THE  CENTRAL  NERVOUS
 SYSTEM  OF  A CONTROLLED SUBSTANCE LISTED IN SCHEDULE I OR II OF SECTION
 THIRTY-THREE HUNDRED SIX OF THIS TITLE; OR
   (II) WITH RESPECT TO A PARTICULAR PERSON, IS  A  SUBSTANCE  THAT  SUCH
 PERSON REPRESENTS OR INTENDS TO HAVE A STIMULANT, DEPRESSANT OR HALLUCI-
 NOGENIC EFFECT ON THE CENTRAL NERVOUS SYSTEM THAT IS SUBSTANTIALLY SIMI-
 LAR  TO  OR  GREATER  THAN  THE  STIMULANT, DEPRESSANT OR HALLUCINOGENIC
 EFFECT ON THE CENTRAL NERVOUS SYSTEM OF A CONTROLLED SUBSTANCE LISTED IN
 SCHEDULE I OR II OF SECTION THIRTY-THREE HUNDRED SIX OF THIS TITLE.
   (B) SUCH TERM SHALL NOT INCLUDE:
   (I) A CONTROLLED SUBSTANCE;
   (II) ANY SUBSTANCE FOR WHICH THERE IS AN APPROVED NEW DRUG APPLICATION
 BY THE FEDERAL FOOD AND DRUG ADMINISTRATION (FDA); OR
   (III) WITH RESPECT TO  A  PARTICULAR  PERSON,  ANY  SUBSTANCE,  IF  AN
 EXEMPTION  IS  IN  EFFECT  FOR  INVESTIGATIONAL  USE FOR THAT PERSON, AS
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD07432-01-7
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.